Quick answers
- What is Duopa?
- Duopa is a brand name of Carbidopa and levodopa, a prescription medicine. The FDA NDC Directory lists 1 Duopa product in 1 strength and form.
- Who makes Duopa?
- Abbvie holds the FDA application for Duopa (NDA203952, approved January 9, 2015).
- Is there a generic or store brand of Duopa?
- Other products of Carbidopa and levodopa are listed with the FDA, but none in exactly the same strength and form as a Duopa product.
- Has Duopa been recalled?
- FDA enforcement reports list 1 recall of Duopa products; the newest started January 13, 2017. A recall usually concerns specific lots, not every product.
What Duopa is
Each Duopa product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Carbidopa and levodopa · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| carbidopa hydrate 4.63 mg/mL · levodopa 20 mg/mL suspension (enteral) | Duopa | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Carbidopa and levodopa →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA203952 | Abbvie | January 9, 2015 | 1 |
Companies that list Duopa
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Duopa products.
- AbbVie Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
January 13, 2017 · Class II · Terminated · D-0495-2017
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life
Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07 — AbbVie Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.